Sorry, you need to enable JavaScript to visit this website.

NYVEPRIA (pegfilgrastim-apgf) Patient Counseling Information

17 PATIENT COUNSELING INFORMATION

Advise the patient to read the FDA-approved patient labeling (Patient Information and Instructions for Use).

Advise patients of the following risks and potential risks with NYVEPRIA:

  • Splenic rupture and splenomegaly
  • Acute Respiratory Distress Syndrome
  • Serious allergic reactions
  • Sickle cell crisis
  • Glomerulonephritis
  • Capillary Leak Syndrome
  • Aortitis

Instruct patients who self-administer NYVEPRIA using the single-dose prefilled syringe of the:

  • Importance of following the Instructions for Use.
  • Dangers of reusing syringes.
  • Importance of following local requirements for proper disposal of used syringes.

This product's label may have been updated. For full prescribing information, please visit www.pfizer.com.

Did you find an answer to your question? Yes No
Did you find an answer to your question? Yes No